Cell and Gene Logistics

  1. MACS® Cell Storage Solution 11/5/2024

    Sometimes, primary cells cannot be used immediately for analysis, or they need to be shipped to different locations to be analyzed. If the cells are to be used within a few days, it is essential to store them in a supporting medium to ensure that cell viability and composition of the cell suspensions are preserved, as well as cell functionality is maintained.

  2. Expert Insights In Navigating CGT's Complex Supply Chain 10/30/2024

    Examine insights shared during Cencora's ThinkLive Cell and Gene Therapy Summit 2024 that shed light on the challenges and opportunities in navigating the complexities of the cell and gene supply chain.

  3. A Comprehensive Guide For Supplier Quality Agreements 10/29/2024

    This overview of SQAs includes a handy matrix template, which is useful for determining who is responsible for managing specific responsibilities.

  4. Audience Q&A | From Bottleneck To Breakthrough: Reimagining The mRNA Therapeutics Supply Chain 10/28/2024

    During every Cell & Gene Live, our expert panelists provide actionable responses to real-time questions from the audience. Here, panelists share information on categorizing raw materials, linear DNA, the future of the mRNA supply chain, and more.

  5. Tips For Scaling mRNA Therapeutics 10/28/2024

    In this segment, Joseph Barberio of Strand Therapeutics and Christian Moreno of Nutcracker Therapeutics share their insight on what’s needed to achieve success in scaling mRNA therapeutics.

  6. Is Cold Chain Really A Challenge Facing mRNA Therapeutics? 10/28/2024

    mRNA product storage can be challenging due to extremely low temperature requirements. Here, Joseph Barberio of Strand Therapeutics and Christian Moreno of Nutcracker Therapeutics share their take on existing cold chain challenges.

  7. Tackling The Standardization Issue For mRNA Therapeutics 10/28/2024

    This segment features a discussion around the obstacles to establishing a standardized production pipeline for mRNA therapeutics across the industry as well as some the approaches being considered to standardize cold chain management protocols for mRNA products.

  8. Regulatory Considerations For The mRNA Platform 10/28/2024

    Joseph Barberio of Strand Therapeutics and Christian Moreno of Nutcracker Therapeutics share how their companies ensure data integrity and privacy compliance throughout R&D and manufacturing.

  9. Top Bottlenecks Facing mRNA Supply Chain 10/28/2024

    In this first segment from Cell & Gene Live, we explore the state of the mRNA therapeutics supply chain and the major bottlenecks that exist today, including non-GMP grade reagents to sourcing DNA.

  10. The Unique Challenges Of The Cell & Gene Therapy Supply Chain 10/28/2024

    Cell and gene therapies present unique logistical challenges for the supply chain, requiring careful consideration of factors like shelf life, packaging, temperature, and chain of custody.